The emergence of mecC methicillin-resistant Staphylococcus aureus (MRSA) poses a diagnostic challenge for clinical microbiology laboratories. Using the Vitek 2 system, we tested a panel of 896 Staphylococcus aureus isolates and found that an oxacillinsensitive/cefoxitin-resistant profile had a sensitivity of 88.7% and a specificity of 99.5% for the identification of mecC MRSA isolates. The presence of the mecC gene, determined by bacterial whole-genome sequencing, was used as the gold standard. This profile could provide a zero-cost screening method for identification of mecC-positive MRSA strains. Copyright © 2013, American Society for Microbiology.
CITATION STYLE
Cartwright, E. J. P., Paterson, G. K., Raven, K. E., Harrison, E. M., Gouliouris, T., Kearns, A., … Török, M. E. (2013). Use of Vitek 2 antimicrobial susceptibility profile to identify mecC in methicillin-resistant Staphylococcus aureus. Journal of Clinical Microbiology, 51(8), 2732–2734. https://doi.org/10.1128/JCM.00847-13
Mendeley helps you to discover research relevant for your work.